Filtered By:
Condition: Heart Attack
Procedure: Coronary Artery Bypass Graft
This page shows you your search results in order of relevance. This is page number 20.
Order by Relevance | Date
Total 1114 results found since Jan 2013.
Icosapent Ethyl Reduces Ischemic Events in Patients with a History of Prior Coronary Artery Bypass Grafting: REDUCE-IT CABG
Conclusions: In REDUCE-IT patients with a history of CABG, treatment with icosapent ethyl was associated with significant reductions in first and recurrent ischemic events.PMID:34710343 | DOI:10.1161/CIRCULATIONAHA.121.056290
Source: Circulation - October 28, 2021 Category: Cardiology Authors: Subodh Verma Deepak L Bhatt Ph Gabriel Steg Michael Miller Eliot A Brinton Terry A Jacobson Nitish K Dhingra Steven B Ketchum Rebecca A Juliano Lixia Jiao Ralph T Doyle Craig Granowitz C Michael Gibson Duane Pinto Robert P Giugliano Matthew J Budoff R Pre Source Type: research
A systematic review and meta-analysis of randomized controlled studies comparing off-pump versus on-pump coronary artery bypass grafting in the elderly
CONCLUSIONS: Data from RCTs in elderly patients showed that OPCAB and ONCAB provide similar mid-term results. OPCAB was associated with a higher risk of early rerevascularization. As CABG on the elderly is still insufficiently explored, further RCTs, specifically designed targeting this population, are needed to establish a better CABG strategy for these patients.PMID:34792312 | DOI:10.23736/S0021-9509.21.12012-9
Source: The Journal of Cardiovascular Surgery - November 18, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Rui J Machado Francisca A Saraiva Jennifer Mancio Patr ícia Sousa Rui J Cerqueira Ant ónio S Barros Andr é P Lourenço Adelino F Leite-Moreira Source Type: research
Treatment of chronic total occlusion with percutaneous coronary intervention is associated with improved survival as compared to medical treatment alone: insights from a single-centre registry
Rev Cardiovasc Med. 2021 Dec 22;22(4):1629-1632. doi: 10.31083/j.rcm2204169.ABSTRACTSymptom relief is currently the main indication to perform percutaneous coronary intervention (PCI) of chronic total occlusion (CTO). So far, none of the randomized trials for CTO treatment have demonstrated improved survival after PCI compared to optimal medical treatment (OMT) alone. We investigated whether CTO PCI in addition to OMT could improve survival over OMT alone. Data of 1004 patients with a treated CTO was analysed. Patients with acute coronary syndrome and who underwent coronary artery bypass graft surgery (CABG) were excluded,...
Source: Reviews in Cardiovascular Medicine - December 27, 2021 Category: Cardiology Authors: Povilas Budrys Vilhelmas Bajoras Michael Rees Ieva Marija Saule Giedrius Davidavicius Andrius Berukstis Arvydas Baranauskas Source Type: research
